Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Warning Letter Urges St. Gobain To Get Hip To QSR Regs

This article was originally published in The Gray Sheet

Executive Summary

Saint Gobain Advanced Ceramics Desmarquest did not adaquately verify and validate changes it made to its manufacturing process in 1998, FDA asserts in a recent warning letter outlining quality system reg (QSR) deficiencies related to certain artificial hip components
Advertisement

Related Content

Zimmer Will Seek Compensation From St. Gobain For Revision Surgery
French Health Authority Sparks Worldwide Recall of Zirconia Femoral Heads
French Health Authority Sparks Worldwide Recall of Zirconia Femoral Heads
Advertisement
UsernamePublicRestriction

Register

MT016539

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel